Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3893017rdf:typepubmed:Citationlld:pubmed
pubmed-article:3893017lifeskim:mentionsumls-concept:C0268708lld:lifeskim
pubmed-article:3893017lifeskim:mentionsumls-concept:C0205329lld:lifeskim
pubmed-article:3893017lifeskim:mentionsumls-concept:C1705994lld:lifeskim
pubmed-article:3893017lifeskim:mentionsumls-concept:C1513492lld:lifeskim
pubmed-article:3893017pubmed:issue5lld:pubmed
pubmed-article:3893017pubmed:dateCreated1985-8-22lld:pubmed
pubmed-article:3893017pubmed:abstractTextA severe rapidly progressive neuropathy is described in 4 young male adults with end-stage renal failure, 3 of whom had accelerated hypertension. The onset of symptoms developed after regular haemodialysis had been started and in all 4 patients was closely associated with a septicaemic illness. In 2 patients, renal transplantation led to considerable clinical improvement, and in a third patient charcoal haemoperfusion halted further clinical progression of the neuropathy. This improvement was not reflected by the nerve conduction studies which remained grossly impaired. A possible ischaemic aetiology related to accelerated hypertension and septicaemia is suggested for this unusual variant of uraemic neuropathy.lld:pubmed
pubmed-article:3893017pubmed:languageenglld:pubmed
pubmed-article:3893017pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3893017pubmed:citationSubsetIMlld:pubmed
pubmed-article:3893017pubmed:statusMEDLINElld:pubmed
pubmed-article:3893017pubmed:monthMaylld:pubmed
pubmed-article:3893017pubmed:issn0001-6314lld:pubmed
pubmed-article:3893017pubmed:authorpubmed-author:WestonM JMJlld:pubmed
pubmed-article:3893017pubmed:authorpubmed-author:BewickMMlld:pubmed
pubmed-article:3893017pubmed:authorpubmed-author:ParsonsVVlld:pubmed
pubmed-article:3893017pubmed:authorpubmed-author:McGonigleR...lld:pubmed
pubmed-article:3893017pubmed:issnTypePrintlld:pubmed
pubmed-article:3893017pubmed:volume71lld:pubmed
pubmed-article:3893017pubmed:ownerNLMlld:pubmed
pubmed-article:3893017pubmed:authorsCompleteYlld:pubmed
pubmed-article:3893017pubmed:pagination379-84lld:pubmed
pubmed-article:3893017pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:meshHeadingpubmed-meshheading:3893017-...lld:pubmed
pubmed-article:3893017pubmed:year1985lld:pubmed
pubmed-article:3893017pubmed:articleTitleProgressive, predominantly motor, uraemic neuropathy.lld:pubmed
pubmed-article:3893017pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3893017pubmed:publicationTypeCase Reportslld:pubmed